Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609

Watchlist Manager
Shanghai HeartCare Medical Technology Corp Ltd Logo
Shanghai HeartCare Medical Technology Corp Ltd
HKEX:6609
Watchlist
Price: 31.45 HKD -0.79% Market Closed
Market Cap: 1.2B HKD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

Price Targets Summary
Shanghai HeartCare Medical Technology Corp Ltd

Wall Street analysts forecast Shanghai HeartCare Medical Technology Corp Ltd stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai HeartCare Medical Technology Corp Ltd is 20.4 HKD with a low forecast of 20.2 HKD and a high forecast of 21 HKD.

Lowest Forecast
Wall Street Target
20.2 HKD
36% Downside
Average Forecast
Wall Street Target
20.4 HKD
35% Downside
Highest Forecast
Wall Street Target
21 HKD
33% Downside
Lowest
Price Target
20.2 HKD
36% Downside
Average
Price Target
20.4 HKD
35% Downside
Highest
Price Target
21 HKD
33% Downside
Shanghai HeartCare Medical Technology Corp Ltd Competitors:
Price Targets
R
228850
Rayence Co Ltd
45% Upside
S
SUS
Surgical Science Sweden AB
58% Upside
CTSO
Cytosorbents Corp
614% Upside
Q
688677
Qingdao NovelBeam Technology Co Ltd
68% Upside
R
228850
Rayence Co Ltd
45% Upside
S
SUS
Surgical Science Sweden AB
58% Upside
CTSO
Cytosorbents Corp
614% Upside
Q
688677
Qingdao NovelBeam Technology Co Ltd
68% Upside
M
MLSS
Milestone Scientific Inc
119% Upside
S
605186
Shanghai General Healthy Information and Technology Co Ltd
23% Upside
MOVE
Medacta Group SA
17% Upside
7733
Olympus Corp
48% Upside

Revenue
Forecast

Revenue Estimate
Shanghai HeartCare Medical Technology Corp Ltd

For the last 3 years the compound annual growth rate for Shanghai HeartCare Medical Technology Corp Ltd's revenue is 152%. The projected CAGR for the next 3 years is 32%.

152%
Past Growth
32%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shanghai HeartCare Medical Technology Corp Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
13%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Shanghai HeartCare Medical Technology Corp Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
24%
Average Beat
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai HeartCare Medical Technology Corp Ltd's stock price target?
Price Target
20.4 HKD

According to Wall Street analysts, the average 1-year price target for Shanghai HeartCare Medical Technology Corp Ltd is 20.4 HKD with a low forecast of 20.2 HKD and a high forecast of 21 HKD.

What is Shanghai HeartCare Medical Technology Corp Ltd's Revenue forecast?
Projected CAGR
32%

For the last 3 years the compound annual growth rate for Shanghai HeartCare Medical Technology Corp Ltd's revenue is 152%. The projected CAGR for the next 3 years is 32%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 242,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.